Trial intelligence / Profile preview

Plenvu versus Moviprep for bowel cleansing before screening colonoscopy

2018-003304-39Phase 4Completed

Sponsor
Morten Rasmussen
Start
Oct 2018
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, open-label trial of polyethylene glycol + electrolytes + ascorbic acid and macrogol (2 arms), sponsored by Morten Rasmussen. Primary endpoint: Bowel cleansing success. Started Oct 2018; status: completed.

02

Drugs

polyethylene glycol + electrolytes + ascorbic acidmacrogol

Beyond the preview

Go deeper on 2018-003304-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-003304-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call